Traders Buy Shares of C.R. Bard Inc. (BCR) on Weakness
Traders purchased shares of C.R. Bard Inc. (NYSE:BCR) on weakness during trading hours on Friday. $17.41 million flowed into the stock on the tick-up and $10.62 million flowed out of the stock on the tick-down, for a money net flow of $6.79 million into the stock. Of all equities tracked, C.R. Bard had the 56th highest net in-flow for the day. C.R. Bard traded down ($0.29) for the day and closed at $221.21
A number of research firms recently commented on BCR. Zacks Investment Research downgraded C.R. Bard from a “buy” rating to a “hold” rating in a report on Thursday, August 4th. Morgan Stanley reiterated a “hold” rating and issued a $240.00 price objective on shares of C.R. Bard in a report on Thursday, July 28th. Leerink Swann reiterated a “market perform” rating and issued a $233.00 price objective (down previously from $240.00) on shares of C.R. Bard in a report on Thursday, July 28th. JPMorgan Chase & Co. upped their price objective on C.R. Bard from $214.00 to $225.00 and gave the company a “neutral” rating in a report on Wednesday, July 27th. Finally, BMO Capital Markets reiterated a “hold” rating and issued a $240.00 price objective on shares of C.R. Bard in a report on Wednesday, July 27th. Thirteen investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. The stock has an average rating of “Hold” and a consensus target price of $232.85.
The company has a market cap of $16.25 billion and a price-to-earnings ratio of 51.44. The stock has a 50 day moving average of $223.14 and a 200-day moving average of $214.80.
C.R. Bard (NYSE:BCR) last announced its earnings results on Tuesday, July 26th. The company reported $2.54 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.47 by $0.07. During the same period in the prior year, the business earned $2.27 earnings per share. The company had revenue of $931.50 million for the quarter, compared to the consensus estimate of $915.22 million. The firm’s revenue for the quarter was up 8.3% on a year-over-year basis. Equities research analysts expect that C.R. Bard Inc. will post $10.17 EPS for the current fiscal year.
An institutional investor recently raised its position in C.R. Bard stock. Ameriprise Financial Inc. increased its stake in C.R. Bard Inc. (NYSE:BCR) by 0.5% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 274,740 shares of the company’s stock after buying an additional 1,433 shares during the period. Ameriprise Financial Inc. owned 0.37% of C.R. Bard worth $52,047,000 at the end of the most recent quarter.
C. R. Bard, Inc (Bard) and its subsidiaries are engaged in designing, manufacturing, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. The Company sells its products to hospitals, individual healthcare professionals, extended care facilities and alternate site facilities.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.